Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Testing effectiveness (Phase 2)Looking for participantsNCT05903833What this trial is testingPembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or RadiotherapyWho this might be right forRecurrent Vulvar CancerPersistent Vulvar CancerMetastatic Vulva Cancer+1 more AGO Research GmbH 42
Early research (Phase 1)Ended earlyNCT03277482What this trial is testingDurvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerWho this might be right forRecurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more Dana-Farber Cancer Institute 16
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT02379520What this trial is testingHPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIAWho this might be right forHuman Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more Baylor College of Medicine 32
Not applicableStudy completedNCT03082950What this trial is testingHPV Infections, Cancer of the Vulva and Therapeutical SuccessWho this might be right forHPVHuman Papilloma Virus University of Luebeck 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT03260023What this trial is testingPhase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M CancersWho this might be right forHPV-Related CarcinomaHPV-Related Cervical CarcinomaHPV-Related Anal Squamous Cell Carcinoma+2 more Transgene 143
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT04357873What this trial is testingEfficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different LocationsWho this might be right forSquamous Cell Lung CancerVulvar CancerPenile Cancer+3 more UNICANCER 112
Testing effectiveness (Phase 2)Looking for participantsNCT06677190What this trial is testingBelzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginWho this might be right forOvarian CancerOvarian CarcinomaEndometrial Cancer+5 more Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625What this trial is testingTalimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more National Cancer Institute (NCI) 68
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT01764789What this trial is testingStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerWho this might be right forAnxiety DisorderDepressionFatigue+17 more Ohio State University Comprehensive Cancer Center 39
Early research (Phase 1)Study completedNCT00842452What this trial is testingTopotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by SurgeryWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more Steven Waggoner, MD 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513What this trial is testingAtezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsWho this might be right forAppendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more M.D. Anderson Cancer Center 133
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Not applicableTemporarily pausedNCT03987555What this trial is testingPaclitaxel Therapeutic Drug Monitoring in Cancer PatientsWho this might be right forSolid Tumor, AdultMetastatic Nonsmall Cell Lung CancerAnatomic Stage IV Breast Cancer AJCC v8+25 more Wake Forest University Health Sciences 22